EEG Changes Due to Melatonin
Melatonin administration produces dose-dependent and timing-dependent changes in EEG spectral power, primarily characterized by increased theta/alpha activity (5.25-9 Hz) during wakefulness and enhanced sleep spindle activity with reduced slow-wave activity during sleep.
Waking EEG Changes
When melatonin is administered during daytime hours, it induces measurable electrophysiological changes that correlate with increased sleepiness:
Theta/alpha band enhancement (5.25-9 Hz): This is the most consistent finding, appearing immediately after melatonin ingestion and preceding subjective sleepiness symptoms 1. The increase in theta/alpha power density serves as an objective marker of fatigue and drowsiness.
Dose and timing matter: A 5 mg dose administered at 1300h or 1800h produces sustained increases in theta/alpha frequencies that parallel subjective sleepiness ratings for 3-5 hours 1. The EEG changes appear before patients report feeling sleepy, making them a more sensitive marker than subjective reports.
Sex and hormonal differences: In reproductive-age women, morning melatonin (9:00 AM) decreases the theta-to-alpha power ratio at 60,240, and 300 minutes post-administration, suggesting a paradoxical alerting effect. This effect is absent in postmenopausal women, indicating hormonal modulation of melatonin's EEG effects 2.
Sleep EEG Changes
During nocturnal sleep, melatonin reorganizes the sleep architecture in characteristic ways:
Increased sleep spindle activity: Melatonin enhances sleep spindle density and power, particularly during NREM sleep 3. This effect makes daytime sleep after melatonin administration resemble nocturnal sleep patterns.
Reduced slow-wave sleep and slow-wave activity: Quantitative EEG analysis reveals decreased delta power (slow waves) during sleep following melatonin administration 3.
Enhanced REM sleep: Higher doses (≥5 mg) increase REM sleep duration 3.
Stage-dependent spectral reorganization: In Alzheimer's disease patients, melatonin induces a relative enhancement of slow-frequency activity and increased spectral segregation during NREM sleep, suggesting optimization of stage-specific neural dynamics 4.
Dose-Dependent Effects and Safety Concerns
Critical caveat: At supraphysiological doses, melatonin's EEG effects reverse dramatically:
High-dose paradoxical excitation: Doses of 100-312 mg/kg in animal models produce seizure-like cortical activity with increased beta and gamma oscillations, tremors, and clonic seizures 5, 6. This represents a shift from inhibitory to proexcitatory neuropharmacological profile.
Anesthetic doses: Very high IV doses (312 mg/kg in rats) produce EEG changes similar to propofol and thiopental, including decreased spectral edge 95% and decreased approximate entropy, but with slower onset and longer duration 5.
Clinical Implications
The EEG changes provide objective evidence that:
Melatonin acts as a chronobiotic first, hypnotic second: The primary mechanism involves circadian phase shifting, with EEG changes reflecting altered circadian timing rather than direct sedation 7.
Timing trumps dose for circadian effects: The phase response curve shows melatonin administered in afternoon/evening advances rhythms, while morning dosing delays them. EEG changes follow this circadian pattern 7.
Physiological doses (0.3-5 mg) are sufficient: Higher doses do not produce proportionally greater circadian effects and may introduce risks 7, 6.
Common pitfall: Using melatonin as a nonspecific hypnotic without considering circadian timing leads to treatment failure. The EEG changes demonstrate that melatonin's effects are time-of-day dependent and require proper chronobiological assessment 8.